Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

NEKTAR
Rezpegaldesleukin shows over 6-month off-treatment durability in alopecia areata

Nektar Therapeutics announced long-term data for rezpegaldesleukin at EADV 2026, showing durable hair regrowth after treatment cessation and initiatio...

USA
USA Rare Earth Names Thras Moraitis New CEO

USA Rare Earth completed its CEO transition naming Thras Moraitis as Chief Executive Officer, with responsibilities divided across Upstream, Midstream...

Veritone,
Veritone Signs Securities Purchase Agreement

Veritone entered into an agreement to issue 20 million shares of common stock to purchasers, with anticipated closing on October 2, 2026....

Brightline
Drone Exec Allan Evans Leads $1.25M PIPE Investment in Brightline Interactive

Brightline Interactive closed a private investment in public equity led by Allan Evans, providing $1.25 million to support its SpatialCore Physical AI...

Valion
Valion advances needle-free Entolimod formulation with Shear Kershman

Valion Bio and Shear Kershman Laboratories announced a successful oral formulation for Entolimod, marking a new needle-free delivery pathway that coul...

Vylor
Corteva announces final results of Vylor's exchange offers for notes

Vylor successfully tendered up to 86.97% of the outstanding $500M EIDP Series 30 notes and up to 95.24% of the $500M Series 32 notes, and approximatel...

Corteva,
Corteva unit completes private offers to exchange notes

Vylor Inc., a Corteva subsidiary, concluded exchange offers and consent solicitations for EIDP notes totalling $1.438B....

Monte
Monte Rosa Announces Positive GFORCE-1 Phase 1 Atherosclerosis Study Results for MRT-8102

Monte Rosa Therapeutics reported degrader MRT-8102 normalized key ASCVD drivers in obese subjects with high CVD risk, revealing a favorable safety pro...

Installed
IBP publishes 2026 ESG report highlighting emissions reduction and community efforts

Installed Building Products Inc. reported progress on environmental and social goals in its 2026 ESG report, which reveals a 21% reduction in Scope 1 ...

MCCORMICK
McCormick reports solid Q3 results, reaffirms fiscal 2026 outlook

Net sales and adjusted earnings per share beat expectations in the third quarter, while the company remains confident in its FY26 guidance and advance...

CHESAPEAKE
Chesapeake Utilities enters equity distribution agreement

Chesapeake Utilities Corp filed an 8-K authorized offering of up to $225M in common stock through a syndicate with Barclays, Citizens JMP, Morgan Stan...

KYNTRA
Kyntra Bio Appoints Director Singer

Kyntra Bio appointed Andrew Singer to its board as independent director and Audit Committee member; simultaneously, Maykin Ho stepped down following e...

ACUITY
Acuity posts FY2026 Q4 sales of $1.2B

Acuity reported solid fiscal 2026 results with net sales growing 7% and adjusted EPS up 11%, underpinned by operational strength and improved cash flo...

Slam
Slam Corp. amends, restates, and consolidates $10.9M promissory note

Slam Corp. executed an amending and restating deed to consolidate nine prior promissory notes into a single $15.5 million obligation....

Keurig
KDP names Russ Torres CEO of future Global Coffee Co.

Keurig Dr Pepper Inc. announced Russ Torres as the CEO of the company's future split-off coffee operating unit, effective November 3, 2026, targeting ...

Fervo
Fervo Energy achieves commercial ops at first geothermal plant

Fervo Energy declared commercial operation at its Cape Station in Utah ahead of schedule, marking the world's first greenfield enhanced geothermal pro...

Ovintiv
Ovintiv Renewed 2026 Share Buy-Back Program

Ovintiv Inc. received regulatory approvals for a renewal of its annual share buy-back program, committing to return at least 60% of its Non-GAAP Free ...

D-Wave
D-Wave launches gate-model simulator beta program

D-Wave Quantum has launched a beta program for its gate-model simulator, allowing select clients early access to the technology. This strategic move a...

Foghorn
Foghorn and Lilly halt FHD-909 development to focus pipeline

Foghorn Therapeutics terminated its collaboration with Eli Lilly to not advance FHD-909, citing insufficient efficacy. The company is reducing its wor...

Sadot
Sadot creates Series D Preferred

Sadot Group Inc. authorized a new series of preferred stock to be issued to a seller. The financial action signals a new capital structure in advance ...